Ledger.Open graph →
SEC Form D · filed November 19, 2019

Velicept Therapeutics, Inc

Offering
$9.2M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Scott S. Morenstein · Wayne, PADirectorStephen S. Tullman · Wayne, PADirectorCory S. Freedland · Wayne, PADirectorJames C. Walker · Wayne, PAExec · DirectorDoug B. Gessl · Wayne, PAExecDavid B. Hirsch, M.D · Wayne, PADirectorJill B. Mast · Wayne, PADirectorAidan S. King, Mba, Cfa · Wayne, PADirectorScott S. Morenstein · Wayne, PADirectorDoug B. Gessl · Wayne, PAExecDavid B. Hirsch, M.D · Wayne, PADirectorJill B. Mast · Wayne, PADirectorStephen S. Tullman · Wayne, PADirectorAidan S. King, Mba, Cfa · Wayne, PADirectorCory S. Freedland · Wayne, PADirectorJames C. Walker · Wayne, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗